[Results of the RALES trial: good news for patients with heart failure and ... for health administrations].
作者信息
Azpitarte Almagro J
机构信息
Servicio de Cardiología, Hospital Universitario Virgen de las Nieves, Granada.
出版信息
Med Clin (Barc). 2000 Apr 15;114(14):545-50. doi: 10.1016/s0025-7753(00)71358-3.
Abstract
摘要
相似文献
1
[Results of the RALES trial: good news for patients with heart failure and ... for health administrations].
Med Clin (Barc). 2000 Apr 15;114(14):545-50. doi: 10.1016/s0025-7753(00)71358-3.
2
[Therapy of heart failure after myocardial infarction. With eplerenone a new course].
MMW Fortschr Med. 2004 Oct 21;146(43):58-9.
3
Economic evaluation of the randomized aldactone evaluation study (RALES): treatment of patients with severe heart failure.
Cardiovasc Drugs Ther. 2002 Jan;16(1):53-9. doi: 10.1023/a:1015371616135.
4
Aldosterone antagonism in heart failure.
Lancet. 1999 Sep 4;354(9181):789-90. doi: 10.1016/S0140-6736(99)80003-8.
5
Expanding the scope of the "polypill" to heart failure.
J Card Fail. 2013 Aug;19(8):540-1. doi: 10.1016/j.cardfail.2013.05.017.
6
[Aldosterone and its antagonists in heart failure].
Presse Med. 2003 Jan 18;32(2):79-87.
7
[Selective aldosterone blocking in heart failure. Eplerenone reduces the risk after infarction].
MMW Fortschr Med. 2003 Oct 30;145(44):42-3.
8
[Aldosterone blocker in heart failure: life prolonging even in mild symptoms].
MMW Fortschr Med. 2010 Dec 2;152(48):12-3.
9
10
Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]).
Am J Cardiol. 1996 Oct 15;78(8):902-7. doi: 10.1016/s0002-9149(96)00465-1.
Zotero 插件